Leqvio (inclisiran) - Novartis
Repatha (evolocumab) - Amgen, Astellas
Comparative Cardiovascular Outcomes Associated with Evolocumab Versus Inclisiran Among Patients with Elevated Lipoprotein(a). (PubMed, Am J Cardiol) - Oct 14, 2026 - No abstract available 
Journal • Cardiovascular
http://www.ncbi.nlm.nih.gov/pubmed/42869405
 
Aaron W Lee; Ali Al-Shammari; Avinav Sanjel; Dalton Buckingham; Grant Ebel; Hani Jneid; Ibrahim Mortada; Jayasurya Dileep; Nicholas Long; Thomas A Blackwell
 
Oct 14, 2026
 
Prev Next